When folding demand exceeds ER capacity—nutrient stress, calcium dyshomeostasis, or glycosylation defects—misfolded proteins accumulate and trigger the UPR. PERK–eIF2α–ATF4, IRE1α–XBP1, and ATF6 arms sense load and reprogram translation, ERAD, and transcription to restore proteostasis; chronic hyperactivation couples to CHOP-driven apoptosis, autophagy, and inflammation.
Transmembrane kinase; phosphorylates eIF2α to attenuate global translation while favoring ATF4.
Kinase/RNase; splices XBP1 to XBP1s; RIDD degrades select ER-localized mRNAs.
Golgi proteolysis releases an active fragment upregulating chaperones and ERAD components.
HGNC symbols for UPR sensors, chaperones/ERAD, integrated stress, and downstream outputs.
For inducers (e.g., thapsigargin), titrate dose and time; for phospho-antibodies, pair totals and kinase-inhibitor controls.
| Arm | Sensor | Key outputs | Notes |
|---|---|---|---|
| PERK | EIF2AK3 | p-eIF2α → ATF4 → CHOP | ISRIB-class tools modulate integrated stress readouts. |
| IRE1α | ERN1 | XBP1s;RIDD | IRE1 RNase inhibitors for branch specificity. |
| ATF6 | ATF6(全长 ER 膜) | Golgi cleavage → nuclear transcription | Often parallels chaperone/ERAD induction. |
GRP78/BiP, calnexin, PDI, PERK, p-PERK, p-eIF2α, ATF4, CHOP, IRE1α, XBP1, ATF6, caspase-3—WB/IHC/IF.
Classical inducers (thapsigargin, tunicamycin, DTT) and PERK/IRE1 inhibitors—for research per datasheets/ethics.
For research use; follow lab SOP, compound datasheets, and ethics approvals.
PERK kinase-domain inhibitor; probe PERK arm dependency.
ISR modulator; reframes p-eIF2α downstream readouts.
IRE1 RNase inhibitors; block XBP1 splicing.
ATF6-arm research tool (literature-dependent).
SERCA inhibitor; canonical ER calcium-depletion stressor.
N-linked glycosylation inhibitor; disrupts glycoprotein folding.
S1P-dependent ATF6 cleavage models (pathogenesis research).
IRE1 kinase inhibitor (distinct from RNase blockers).
The UPR is a central adaptive response to proteotoxic ER stress, crosstalking with lipid metabolism, calcium signaling, and autophagy initiation. In cancer, the UPR can support secretory proteostasis yet be co-opted for survival under nutrient stress—interpret with secretory burden, genetics, and therapy context.
UPR mechanisms
Disease & therapeutic angles